obstructive pulmonary disease. Afr J Biotechnol 111: 207215. 3. Bhattacharjee M, Unni BG, Das S, Deka M, Rao PG, Lung function decline: 1516647 Screening of alpha -1 antitrypsin gene inside a population exposed to coal dust. Int J Biotechnol Mol Biol Res 211:195201. four. Hogg JC Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 364:709721. 5. Piqueras CMG, Cosio MG, Disease on the airways in Chronic Obstructive Pulmonary Illness. Eur Respir J 18 suppl 34: 4149. 6. Repine JE, Bast A, Lankhorst I, Oxidative strain in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 156: 341357. 7. Koyama H, Peptide M price Geddea DM, Genes, Oxidative stress along with the danger of Chronic Obstructive Pulmonary Disease Critique. Thorax suppl 2:1014. 8. Smith CA, Harrison DJ, Association amongst polymorphism and gene for microsomal epoxide hydrolase and susceptibility to emphysema Comments. Lancet 350:630633. 9. Barnes PJ Compact airways in COPD. N Engl J Med 350: 26352637. 10. Hayes JD, Strange RC, Glutathione S- transferase polymorphisms and their biological consequences. Pharmacol 61:154166. 11. Zidzik J, Slaba E, Joppa P, Kluchova Z, Dorkova Z, et al. Glutathione stransferase and microsomal epoxide hydrolase gene polymorophisms and danger of chronic obstructive pulmonary disease in Slovak population. Croat Med J 492:182191 12. Coates J Interpretation of Infrared Spectra: A pratical approach, Encyclopedia of analytical Chemistry. R.A.Meyers ed John Wiley & sons Ltd.Chichester. pp1081510837 13. Love RG, Miller BG, Groat SK, Hagen S, Cowie HA, et al. Respiratory health effects of opencast coalmining: a cross sectional study of current workers. Occup Environ Med 54:416423 14. Sanford AJ, Pane PD, Genetic danger factors for Chronic Obstructive Pulmonary Disease. Clin Chest Med 21: 633643. 15. He JQ, Ruan J, Connett JE, Anthonisen NR, Pare PD, et al. Antioxidant Gene Polymorphism and Susceptibility to a rapid decline in lung function in smokers. Am J Respir Crit care Med 166: 323328. 16. Cheng SL, Yu CJ, Chen CJ, Yang PC, Genetic polymorphism of epoxide hydrolase and Glutathione S Transferase in COPD. Eur Respir J 23:818824. 17. Yim JJ, Yoo CG, Lee CT, Kim YW, Han SK, et al. Lack of association between Glutathione S Transferase polymorphism and COPD in Koreans. Lung 180: 119125. 18. Lu B, He Q, Correlation among exon 5 polymorphism of Glutathione Stransferase P1 gene and susceptibility to Chronic Obstructive Pulmonary Illness in Northern Chinese population of Han nationality living in Beijing. Zhonghua nei Ke Za Zhi. 41:678681. 19. Dockery DW, Pope CA, Xu X, Spengler JD, Ware JH, et al. An Association in between air Pollution and Mortality in six US Cities. N Engl J Med 329: 17539. 20. Laden F, Schwartz J, Speizer FE, Dockery DW, Reduction in Fine Particulate Air Pollution and Mortality: extended follow-up in the Harvard Six Cities Study. Am J Respir Crit Care Med 17: 366772. 21. Brook RD, Franklin B, Cascio W, Hong Y, Howard G, et al. Air 
Pollution and Cardiovascular Illness: a statement for health-care professionals from the expert panel on Population and Prevention Science on the American Heart Association. Circulation 109: 265571. 22. Pope A, Dockery D, Health Effects of Fine Particulate Matter: lines that connect. J Air Waste Manag Assoc 56: 20942. 23. Schwartz J Air Pollution and hospital admissions for cardiovascular disease in Tucson. Epidemiol eight:3717 24. Brabin B, Smith M, Milligan P, Benjamin C, Dunne E, et al. Respiratory Morbidity in Merseys
